PharmaBiome Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.36M

  • Investors
  • 6

PharmaBiome General Information

Description

Developer of biology-based analysis tool designed to formulate fecal microbiota transplant products. The company's platform makes microbiota therapy the new standard for the treatment of intestinal diseases and treats intestinal infections without using fecal transplants, thereby enabling patients to recover from intestinal infections such as difficile infection.

Contact Information

Website
www.pharmabiome.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Wagistrasse 27
  • 8952 Schlieren
  • Switzerland
+41 044 000 00 00

PharmaBiome Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 10-Sep-2021 $2.36M 00.000 000.00 Completed Pre-Clinical Trials
10. Angel (individual) 08-Jul-2020 00.000 00.000 Completed Pre-Clinical Trials
9. Accelerator/Incubator 16-Jan-2020 00000 00.000 Completed Pre-Clinical Trials
8. Accelerator/Incubator 03-Dec-2019 00.000 Completed Startup
7. Angel (individual) 02-May-2019 00000 00.000 00.000 Completed Startup
6. Grant 31-Jul-2018 000.00 00.000 Completed Startup
5. Angel (individual) 23-May-2018 00000 00.000 00.000 Completed Startup
4. Angel (individual) 16-Jun-2017 00000 00000 00.000 Completed Startup
3. Angel (individual) 09-Dec-2016 $124K $124K 00000 Completed Startup
2. Accelerator/Incubator 14-Jun-2016 $133K Completed Startup
To view PharmaBiome’s complete valuation and funding history, request access »

PharmaBiome Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 120,482 $0.109056 $0.91 $0.91 1x $0.91 5.24%
Ordinary 84,338 $0.109056 $0.33 $0.33 1x $0.33 3.67%
To view PharmaBiome’s complete cap table history, request access »

PharmaBiome Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

PharmaBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4188400-A1 Microbial niche mapping Pending 31-Jul-2020 00000000
US-20230227885-A1 Microbial niche mapping Pending 31-Jul-2020 00000000
EP-4045668-A1 Use of glycerol for increasing butyrate production by bacteria in a consortium Pending 15-Oct-2019 00000000
EP-3866819-A1 A method of manufacturing a consortium of bacterial strains Pending 15-Oct-2018 00000000
US-20210355431-A1 Method of manufacturing a consortium of bacterial strains Pending 15-Oct-2018 C12N1/20 0
To view PharmaBiome’s complete patent history, request access »

PharmaBiome Executive Team (7)

Name Title Board Seat Contact Info
Tomas de Wouters Ph.D Co-Founder, Chief Executive Officer & Board Member
Manuel Banz Co-Founder, Chief Financial Officer & Board Member
Florian Rosenthal Ph.D Chief Operating Officer
Cristina de Min SAB Member & Board Member
Christophe Lacroix Ph.D Scientific Co-Founder, SAB Member & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

PharmaBiome Board Members (9)

Name Representing Role Since
Alexey Borichev Self Board Member 000 0000
Christophe Lacroix Ph.D PharmaBiome Scientific Co-Founder, SAB Member & Board Member 000 0000
Cristina de Min PharmaBiome SAB Member & Board Member 000 0000
Erich Greiner Self Chairman of the Board 000 0000
Gerhard Rogler Ph.D PharmaBiome Scientific Co-Founder, Head of SAB & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

PharmaBiome Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaBiome Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Patrik Forrer Angel (individual) 000 0000 000000 0
Thomas Meier Angel (individual) 000 0000 000000 0
BaseLaunch Accelerator/Incubator 000 0000 000000 0
EIT Health Accelerator/Incubator 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial